Search Results 1861-1870 of 4062 for Solid

1. Diverse ways regenerative medicine is advancing health care

   We hope that regenerative sciences will discover and perfect ways to expand this treatment approach to solid cancers, as well," says Dr. Terzic ...

2. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Other completely resected stage 1 solid tumor with low risk for recurrence. Treatment with any prior gene therapy product. Subjects who have received ...

3. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.

4. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria is required except for subjects with bone only disease. All prior ...

5. Clinical trials - Oncology (Medical)

   ... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...

6. Oncology (Medical) - Clinical trials

   ... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined ...

7. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   ... Solid Tumors (RECIST); Prior or concurrent therapy with SSA is permitted; a stable dose at least 2 months prior to study start and must continue on the ...

8. Publications - Leigh L. Speicher, M.D., M.P.H. - Mayo Clinic

   Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of ...

9. Oncology (Medical) - Clinical trials

   ... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...

10. Clinical trials - Oncology (Medical)

    ... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...